BlueRock Therapeutics

08/12/2026

BlueRock is pleased to sponsor the The Michael J. Fox Foundation for Parkinson's Research PDIQ+ You Series, which continues in St. Louis on August 15. BlueRock will be in attendance - stop by and say hello!

Join us in St. Louis for our free educational event designed for people with Parkinson’s and their loved ones. This in-person event features sessions on navigating Parkinson’s, managing care, and the latest research. The accompanying Parter Expo includes information on treatment options and loca...

07/15/2026

We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Learn more at www.bluerocktx.com

07/15/2026

Are clinical trials right for you? Learn more with a webinar by The Michael J. Fox Foundation for Parkinson's Research sponsored by BlueRock.

07/15/2026

Parkinson's treatment has had few advancements in 60 years. Now, cell therapy clinical trials aim to replace the neurons that are lost.​ Click the link below to learn more about the potential of cell therapy for Parkinson's disease.

06/16/2026

Proud moment for the BlueRock team 👏

This year, we set a BlueRock fundraising record—raising more than $18K in support of Bio-Ball and Special Olympics Massachusetts. Even more inspiring? Being part of a broader community effort that brought in over $500K for the 20th BioBall.

A huge thank you to everyone who contributed, participated, and championed the cause. It’s a powerful reminder of what’s possible when our community comes together around a shared mission.

And the best part… we’re just getting started.
See you back at the Garden this fall. 🏀 🗑️ 💙

06/02/2026

Inherited retinal disorders destroy photoreceptor cells. Cell therapy could replace them, thus potentially restoring vision.​ Visit our educational hub to learn about how it could work.​​ 👇

05/28/2026

Parkinson's destroys neurons that produce dopamine. Cell therapy clinical trials are studying whether they can be replaced.​ Check out this new educational hub to learn about how it could work. Link in the comments. 👇🏼

05/22/2026

BlueRock will be in attendance at the 7th World Parkinson Congress May 24-27 in Phoenix. Visit our booth (509) to learn more about our work in neurology.

We also have a poster being presented during the Tuesday Poster Tour from 11:30 AM to 12:30 PM.

05/20/2026

On Clinical Trials Day (May 20), we recognize and thank the individuals and families who make clinical research possible.

To every participant and the care partners and loved ones who support them: your courage, time, and trust are invaluable. Advancing new therapies is not possible without your willingness to take part in research that moves science forward and brings hope to patients everywhere.

At the heart of this work is a deep sense of responsibility. We act with urgency. We are committed to our work because patients, families, and caregivers are counting on us. Our passion, determination, and focus drive us closer to realizing new possibilities in medicine. The actions we take now impact our ability to deliver for each other and for the world.

Today, and every day, we are grateful for your partnership and inspired by your resilience.

04/29/2026

Thank you to Bernard Whitman and Constantin Mitides for visitng BlueRock's New York office and speaking to BlueRockers about their experience with Parkinson's disease. Diagnosed with young-onset at 51, Bernard spoke to the very real challenges of the day-to-day and the need for research and innovative treatment options. It was incredibly motivating during Parkinson's Awareness Month to remind and ground ourselves in what people living with Parkinson's disease are experiencing and how we need to continue to work urgently to bring potential new treatments to patients.

Pictured: Marta Farino-Silva, BlueRock's head of patient advocacy, with Constantin and Bernard in the NYC office.